首页> 美国卫生研究院文献>Veterinary Research >Recombinant chicken interleukin-7 as a potent adjuvant increases the immunogenicity and protection of inactivated infectious bursal disease vaccine
【2h】

Recombinant chicken interleukin-7 as a potent adjuvant increases the immunogenicity and protection of inactivated infectious bursal disease vaccine

机译:重组鸡白介素7作为有效佐剂可提高免疫原性和保护灭活传染性法氏囊病疫苗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our previous work showed that a plasmid-based chicken interleukin-7 (chIL-7) gene expression vector possessed potent adjuvant activity for a VP2 DNA vaccine against chicken infectious bursal disease virus (IBDV). Whether recombinant chIL-7 prepared in procaryotic expression system has the adjuvant activity for inactivated IBDV vaccine remains unknown. Here, we prepared recombinant chIL-7 using an E. coli expression system and analyzed its adjuvant activity for the inactivated IBDV vaccine. The results show that the recombinant chIL-7 was successfully prepared in E. coli using the pET20b vector, which possessed biological activity to stimulate mouse B lymphocyte proliferation. Co-administration of the chIL-7 with inactivated IBDV vaccine significantly increased specific serum antibody titers against IBDV, enhanced lymphocyte proliferation and IFN-γ and IL-4 productions, and increased protection against virulent IBDV infection.
机译:我们以前的工作表明,基于质粒的鸡白介素7(chIL-7)基因表达载体具有针对鸡传染性法氏囊病病毒(IBDV)的VP2 DNA疫苗的有效佐剂活性。在原核表达系统中制备的重组chIL-7是否具有灭活IBDV疫苗的佐剂活性尚不清楚。在这里,我们使用大肠杆菌表达系统制备了重组chIL-7,并分析了其对灭活IBDV疫苗的佐剂活性。结果表明,利用具有刺激小鼠B淋巴细胞增殖的生物学活性的pET20b载体在大肠杆菌中成功制备了重组chIL-7。 chIL-7与灭活的IBDV疫苗共同给药可显着提高针对IBDV的特异性血清抗体滴度,增强的淋巴细胞增殖以及IFN-γ和IL-4的产生,并增强对强力IBDV感染的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号